An immunotherapy conceived at Stanford appeared safe in an early clinical trial. Half of the participants responded positively to the treatment, aimed at triggering macrophages to engulf cancer cells, the researchers reported.
Over 400,000 people have enrolled in a study being conducted by researchers at Stanford and Apple to determine whether a wearable technology can identify irregular heart rhythms suggestive of atrial fibrillation.
Stanford scientists and their collaborators have identified two key genes responsible for the rapid growth of deer antlers. They hope their insights will open the door to new approaches for treating bone diseases and fractures.
Inside Stanford Medicineis a twice-monthly newspaper that reports on the accomplishments and activities of the faculty, staff and students in the Stanford Medicine community. To suggest a story or to get more information, contact editor John Sanford at (650) 723-8309 or email@example.com.
You're receiving this newsletter because you registered with us.
Not interested anymore? Unsubscribe here.